The good news is that a division of Johnson and Johnson appears to be acting promptly to solve a problem. The bad news is that the consumers who use the 43 recalled products for children and infants are going to be wondering if their children have suffered any harm from them..
Federal regulators have identified what they called deficiencies at a Johnson and Johnson manufacturing facility. The products include liquid versions of Tylenol, Motrin, Zyrtec and Benadryl. The FDA called the potential for health problems "remote."
This is from the J & J subsidiary’s press release on the subject: